Publications by authors named "Fabio Arias"

Claim this Profile
T
Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.
Fabio Arias, Sumati Rohilla, Yudibeth Sixto-López, Koral S E Richard, Sandeep Das

J Med Chem· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage.
Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, Nirvana Shaaban, Dhananjay Kumar, Fabio Arias

Arterioscler Thromb Vasc Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.
Sandeep Das, Alexandra C Finney, Sumit Kumar Anand, Sumati Rohilla, Yuhao Liu, Fabio Arias

Nat Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NMR spectroscopy study of new imidamide derivatives as nitric oxide synthase inhibitors.
Fabio Arias, María Encarnación Camacho, María Dora Carrión

Magn Reson Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactive imidamide-based compounds targeted against nitric oxide synthase.
Fabio Arias, Francisco Franco-Montalban, Miguel Romero, Juan Duarte, M Dora Carrión

Bioorg Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laryngeal Myofibroblastic Tumor: A New Therapeutic Approach. A Case Report.
Javier Gómez-Hervás, Manuel Moreno-Romera, Fabio Hugo Escobar Arias, Esteban Merino Gálvez

Ear Nose Throat J· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
Fabio Arias, Francisco Franco-Montalban, Miguel Romero, M Dora Carrión, M Encarnación Camacho

Bioorg Med Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.
Cristina Maccallini, Fabio Arias, Marialucia Gallorini, Pasquale Amoia, Alessandra Ammazzalorso

ACS Med Chem Lett· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Cyclosiphonodictyol A and Its Bis(sulfato).
Juan A Gil, Fabio Arias, Rachid Chahboun, Enrique Alvarez-Manzaneda

J Org Chem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protecting-Group-Free Synthesis of Cassane-Type Furan Diterpenes via a Decarboxylative Dienone-Phenol Rearrangement.
Houda Zentar, Fabio Arias, Ali Haidour, Ramón Alvarez-Manzaneda, Rachid Chahboun

Org Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
M Encarnación Camacho, Mariem Chayah, M Esther García, Nerea Fernández-Sáez, Fabio Arias

Arch Pharm (Weinheim)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis